"IMP manufacturing services for multi and single-center clinical trials in EU"
Insights from Parisa Mozaffari, Qualified Person and Head of IMP at Profil:
The live online seminar will take place on May 18th, 2021 at 4 PM CEST.
You will benefit by learning about:
- An overview of the manufacturing of IMPs for clinical trials
- How to ensure IMP access during a clinical trial
- What are the pitfalls of IMP logistics
- Profil and its GMP certified manufacturing facility
Online Seminar synopsis
There are many issues that clinical project managers need to address while preparing and running a clinical trial in Europe. One key issue is manufacturing and supply of the investigational medicinal products (IMPs) according to EU regulations.
The manufacture and packaging of investigational medicinal products for human use in clinical trials may appear to be a straightforward exercise. In this webinar you will hear about the pitfalls of IMP logistics for clinical trials in the EU. You will learn what to pay attention to when choosing a provider for IMP preparation, blinding, labelling and logistics.
After learning about these processes in this online seminar, our expert for GMP and IMP will highlight why Profil is your partner of choice for manufacturing and distribution of IMPs in small scale.
We have offered these services for many years utilizing our own GMP certified manufacutring facility.
This seminar is intended for anyone involved in the process of planning a multi and single -center clinical trial in Europe facing IMP supply questions
We invite anyone who is involved in the field of IMP and GMP to join this session
You will understand how to ensure IMP access during a clinical trial.
Meet the presenter
Parisa Mozaffari has an academic background as a pharmacist at the University Bonn. She joined Profil in 2017 as a Qualified Person. Since then she has been responsible for all IMP related manufacturing processes and general IMP related study inquiries.
In her role at Profil, Parisa has carried out numerous QP audits in Asia and Europe and she regularly coordinates IMP imports for EU clinical trials.
Share this online seminar with your colleagues: